ESTROGEN AND PROGESTERONE-RECEPTOR CONTENT OF GNRH ANALOG PRETREATED AND UNTREATED UTERINE LEIOMYOMATA

Objectives: The steroid receptor concentration and the histological morphology of uterine leiomyomata in premenopausal patients undergoing myomectomy therapy with and without a preoperative GnRH analogue, was analysed to evaluate whether the GnRH analogue therapy leads to important hormonal receptor changes, histomorphological changes and a significant shrinkage of the leiomyomata. Study design: Sixty-one GnRH analogue pretreated leiomyomata and 28 untreated leiomyomata were analysed. To determine the estrogen and progesterone receptor concentrations, immunohistochemical techniques were used and quantified with the immune-reactive score (IRS-score). The leiomyomata were divided into cellular I ich; normal, hyaline or cystic degenerated and necrotic according to their histology. Results: The GnRH analogue pretreated leiomyomata group showed higher levels of estrogen and progesterone receptors than the untreated group (37.7%, of the GnRH analogue group had a high positive and 29.5%;, a moderate positive estrogen receptor status whereas high levels of estrogen receptor could be found in only 14.3% of the untreated group). The leiomyomata of both groups with the exception of the necrotic ones, were estrogen and progesterone receptor positive. Conclusions: Our study suggests that pretreatment of uterine leiomyomata leads to a significant increase in the hormonal receptor concentration of these benign tumors. If pretreated leiomycomata are not removed surgically immediately after the therapy, a rapid regrowth can occur and again cause clinical symptoms.